{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:35:26Z","timestamp":1784903726058,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T00:00:00Z","timestamp":1433030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s11255-015-1018-9","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T06:19:46Z","timestamp":1432966786000},"page":"1059-1066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin"],"prefix":"10.1007","volume":"47","author":[{"given":"Yang Hyun","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Il","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Suck","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Song","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Chang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Ouck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Deuk","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,31]]},"reference":[{"issue":"2","key":"1018_CR1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2011.05.015","volume":"63","author":"PR Hsueh","year":"2011","unstructured":"Hsueh PR, Hoban DJ, Carmeli Y et al (2011) Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J infect 63(2):114\u2013123","journal-title":"J infect"},{"issue":"5","key":"1018_CR2","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103\u2013e120","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1018_CR3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jinf.2012.01.010","volume":"64","author":"S Aguilar-Duran","year":"2012","unstructured":"Aguilar-Duran S, Horcajada JP, Sorli L et al (2012) Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections. J Infect 64(5):478\u2013483","journal-title":"J Infect"},{"issue":"10","key":"1018_CR4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE et al (2002) Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791\u2013797","journal-title":"Ann Intern Med"},{"issue":"2","key":"1018_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0891-5520(03)00006-0","volume":"17","author":"K Gupta","year":"2003","unstructured":"Gupta K (2003) Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 17(2):243\u2013259","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"1018_CR6","first-page":"CR75-9","volume":"14","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Polemis M, Alexiou VG, Marini-Mastrogiannaki A, Kremastinou J, Vatopoulos AC (2008) Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece. Med Sci Mon 14(2):CR75-9","journal-title":"Med Sci Mon"},{"issue":"9","key":"1018_CR7","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/AAC.01760-09","volume":"54","author":"S Auer","year":"2010","unstructured":"Auer S, Wojna A, Hell M (2010) Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob Agents Chemother 54(9):4006\u20134008","journal-title":"Antimicrob Agents Chemother"},{"key":"1018_CR8","series-title":"Seventeenth informational supplement. Document M100-S20","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing., Seventeenth informational supplement. Document M100-S20CLSI, Wayne"},{"issue":"3","key":"1018_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","volume":"16","author":"JS Garner","year":"1988","unstructured":"Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16(3):128\u2013140","journal-title":"Am J Infect Control"},{"issue":"5","key":"1018_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA (2008) CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309\u2013332","journal-title":"Am J Infect Control"},{"issue":"8","key":"1018_CR11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/00365548.2011.572907","volume":"43","author":"YE Ha","year":"2011","unstructured":"Ha YE, Kang CI, Joo EJ et al (2011) Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis. Scand J Infect Dis 43(8):587\u2013595","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"1018_CR12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/1469-0691.12089","volume":"19","author":"JP Horcajada","year":"2013","unstructured":"Horcajada JP, Shaw E, Padilla B et al (2013) Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect 19(10):962\u2013968","journal-title":"Clin Microbiol Infect"},{"key":"1018_CR13","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1086\/323810","volume":"33","author":"M Velasco","year":"2001","unstructured":"Velasco M, Horcajada JP, Mensa J et al (2001) Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33:1682\u20131686","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1018_CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","volume":"32","author":"National Nosocomial Infections Surveillance S","year":"2004","unstructured":"National Nosocomial Infections Surveillance S (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32(8):470\u2013485","journal-title":"Am J Infect Control"},{"issue":"4","key":"1018_CR15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","volume":"57","author":"E Calbo","year":"2006","unstructured":"Calbo E, Romani V, Xercavins M et al (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemoth 57(4):780\u2013783","journal-title":"J Antimicrob Chemoth"},{"issue":"3","key":"1018_CR16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkn514","volume":"63","author":"M Ortega","year":"2009","unstructured":"Ortega M, Marco F, Soriano A et al (2009) Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemoth 63(3):568\u2013574","journal-title":"J Antimicrob Chemoth"},{"issue":"2","key":"1018_CR17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","volume":"16","author":"OK Azap","year":"2010","unstructured":"Azap OK, Arslan H, Serefhanoglu K et al (2010) Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 16(2):147\u2013151","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1018_CR18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","volume":"49","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Rodriguez-Bano J, Arslan H et al (2009) A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49(5):682\u2013690","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1018_CR19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4111\/kju.2010.51.7.492","volume":"51","author":"DS Lee","year":"2010","unstructured":"Lee DS, Lee CB, Lee SJ (2010) Prevalence and risk factors for extended spectrum beta-lactamase-producing uropathogens in patients with urinary tract infection. Korean J Urol 51(7):492\u2013497","journal-title":"Korean J Urol"},{"issue":"4","key":"1018_CR20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18(4):657\u2013686","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1018_CR21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1473-3099(14)70950-8","volume":"15","author":"PN Harris","year":"2015","unstructured":"Harris PN, Tambyah PA, Paterson DL (2015) \u03b2-lactam and \u03b2-lactamase inhibitor combinations in the treatment of extended-spectrum \u03b2-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? Lancet Infect Dis 15(4):475\u2013485","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1018_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jinf.2011.02.009","volume":"62","author":"YH Chen","year":"2011","unstructured":"Chen YH, Hsueh PR, Badal RE et al (2011) Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 62(4):280\u2013291","journal-title":"J Infect"},{"issue":"5","key":"1018_CR23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkq051","volume":"65","author":"RJ Chislett","year":"2010","unstructured":"Chislett RJ, White G, Hills T, Turner DP (2010) Fosfomycin susceptibility among extended-spectrum-beta-lactamase-producing Escherichia coli in Nottingham, UK. J Antimicrob Chemother 65(5):1076\u20131077","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"1018_CR24","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jac\/dkq237","volume":"65","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Vouloumanou EK, Togias AG, Karadima M et al (2010) Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 65(9):1862\u20131877","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1018_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2006.08.039","volume":"29","author":"H Pullukcu","year":"2007","unstructured":"Pullukcu H, Tasbakan M, Sipahi OR, Yamazhan T, Aydemir S, Ulusoy S (2007) Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections. Int J Antimicrob Agents 29(1):62\u201365","journal-title":"Int J Antimicrob Agents"},{"issue":"2\u20133","key":"1018_CR26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000085625","volume":"51","author":"G Bonfiglio","year":"2005","unstructured":"Bonfiglio G, Mattina R, Lanzafame A, Cammarata E, Tempera G (2005) Italian Medici Medicina Generale G. Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study. Chemotherapy 51(2\u20133):162\u2013166","journal-title":"Chemotherapy"},{"issue":"1","key":"1018_CR27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10156-010-0092-2","volume":"17","author":"T Matsumoto","year":"2011","unstructured":"Matsumoto T, Muratani T, Nakahama C, Tomono K (2011) Clinical effects of 2\u00a0days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women. Journal Infect Chemother 17(1):80\u201386","journal-title":"Journal Infect Chemother"},{"issue":"11","key":"1018_CR28","doi-asserted-by":"crossref","first-page":"e966","DOI":"10.1016\/j.ijid.2013.04.005","volume":"17","author":"T Demir","year":"2013","unstructured":"Demir T, Buyukguclu T (2013) Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey. Int J Infect Dis 17(11):e966\u2013e970","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1018_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinf.2007.10.001","volume":"56","author":"J Valles","year":"2008","unstructured":"Valles J, Calbo E, Anoro E et al (2008) Bloodstream infections in adults: importance of healthcare-associated infections. J Infect 56(1):27\u201334","journal-title":"J Infect"},{"issue":"3","key":"1018_CR30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s15010-013-0441-z","volume":"41","author":"B Kim","year":"2013","unstructured":"Kim B, Kim J, Seo MR et al (2013) Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea. Infection 41(3):603\u2013612","journal-title":"Infection"},{"issue":"1","key":"1018_CR31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diagmicrobio.2006.11.015","volume":"58","author":"KS Ko","year":"2007","unstructured":"Ko KS, Suh JY, Peck KR et al (2007) In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood. Diagn Microbiol Infect Dis 58(1):111\u2013115","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"1018_CR32","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/jac\/dks319","volume":"67","author":"SY Lee","year":"2012","unstructured":"Lee SY, Park YJ, Yu JK et al (2012) Prevalence of acquired fosfomycin resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother 67(12):2843\u20132847","journal-title":"J Antimicrob Chemother"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-1018-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1018-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:02:02Z","timestamp":1559390522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-1018-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,31]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-1018-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,31]]}}}